ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
P. Rajeshbabu1, K.Priadharsini2, S.U. Mohammed Riyaz3 and Manikandan Dhayalan4
1Sai Biotech, Hosur, Tamil Nadu – 635 109, India.
2Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai – 600 025, India.
3Molecular Biology Unit, PG and Research Department of Biotechnology, Islamiah College (Autonomous), Vaniyambadi, Tamil Nadu – 635752, India.
4Anticancer Bioscience, Tianfu International Bio town, Chengdu 610000, China.
J Pure Appl Microbiol. 2022;16(2):763-768 | Article Number: 7279 | © The Author(s). 2022
Received: 27/08/2021 | Accepted: 07/03/2022 | Published online: 25/04/2022
Issue online: June 2022

Novel coronavirus pneumonia (COVID-19) is a respiratory infection caused by infecting lungs and respiratory pathways which has rapidly spread to 216 countries. It is causing serious harm to the world’s entire population and a huge social burden, which can spread mainly by droplets produced during coughing and sneezing from animal to animal or human to human. There were no drugs or vaccines available as of May 2020. Though the severity and infectious behavior and mortality rate of COVID-19 led to the discovery of various vaccines and drugs that are available to control COVID-19 pandemic. India has two vaccines: Covishield and Covaxin approved by the Government of India on 2nd January 2021. Of this sudden and lethal disease, the traditional Indian siddha medicine was proficient as an alternative source, in performing differentiation with fewer side effects and better ability to prevent and control. In this article, we have comprehensively analyzed the case study and the efficacy of Indian Siddha medicine Kabasura Kudineer chooranam. Naturally occurring Indian Siddha medicinal (Kabasura Kudineer chooranam) compounds and its treatment as prevention measures so as to provide strategy and suggestions for the disease COVID-19 are discussed.


COVID-19, Kabasura Kudineer chooranam, siddha drugs

Article Metrics

Article View: 33

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.